The purpose of our study was to compare the 3-year of follow-up clinical outcomes in patients suffering from left main coronary artery disease (LMCAD) treated either by percutaneous coronary intervention (PCI) or by coronary artery bypass grafting (CABG) depending on SYNTAX score tertiles. The primary end point of the study was all-cause mortality for the PCI arm versus CABG arm depending on SYNTAX score tertiles. The secondary end points were the recurrence of angina pectoris following revascularization, the acute nonfatal myocardial infarction, the reduction of the left ventricular ejection fraction or the need for myocardial revascularization. With regard to patients with LMCAD, at low risk (SYNTAX score 0-22) there was no difference in the frequency of end-point occurrence among patients treated by PCI compared to CABG. Also, the tendency to increase end point occurrence in patients with LMCAD treated by PCI compared to patients treated by CABG was more evident in patients at intermediate risk, but the significant statistical difference was recorded only in the occurrence of acute myocardial infarction. Regarding the patients with LMCAD at high risk (SYNTAX score over 33) the endpoint occurrence was significantly increased, statistically significant differences were recorded in all evaluated endpoints. In conclusion, coronary artery bypass grafting remains the standard treatment for high-risk patients with complex lesions, while for patients with LMCAD at low or intermediate risk, percutaneous coronary intervention by stent implantation remains an alternative that does not pose significant risks.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592662PMC
http://dx.doi.org/10.12865/CHSJ.45.01.12DOI Listing

Publication Analysis

Top Keywords

syntax score
20
coronary artery
16
patients lmcad
16
depending syntax
12
patients
9
left main
8
main coronary
8
artery disease
8
clinical outcomes
8
lmcad treated
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!